+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CSF somatostatin in Alzheimer's disease



CSF somatostatin in Alzheimer's disease



Neurobiology of Aging 5(3): 187-189



Studies have previously demonstrated low somatostatin levels in autopsy cortical tissue from Alzheimer's disease (AD) patients and low somatostatin levels in CSF obtained from subjects with dementia. We evaluated levels of this peptide in 21 non-depressed subjects, 10 with AD, 2 with Parkinson's disease (PD), and 9 with other neurological conditions. The AD patients had significantly lower mean CSF somatostatin than the "other" neurological patients (14.6 +/- 1.5 S.E.M. versus 26.7 +/- 3.2 pg/ml, p less than 0.005). A demented PD subject had a level in the range of the AD group, while the non-demented PD patient had a value above this range. Thus, all 11 patients with AD or PD dementia, analogous disorders, had levels below 21.8 mg/ml, while 7 of the 10 remaining patients had values above 21.8 pg/ml. Age did not explain this finding.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042429366

Download citation: RISBibTeXText

PMID: 6151123

DOI: 10.1016/0197-4580(84)90061-7


Related references

The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease. Neuroscience 122(2): 437-447, 2003

Somatostatin and cognitive functions in Alzheimer's disease--the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine. Neuroscience Letters 130(1): 46-48, 1991

Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. Neurobiology of Aging 2(1): 9, 1981

Effects of bushen yizhi recipe on somatostatin-like immunopositive and somatostatin messenger ribonucleic acid expressed-positive neurons in Alzheimer's disease model rats. Zhongguo Zhong Xi Yi Jie he Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 20(7): 533-535, 2000

Reduced somatostatin like immuno reactivity in cerebral cortex from cases of alzheimer disease and alzheimer senile dementia. Nature (London) 288(5788): 279-280, 1980

Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type. Psychoneuroendocrinology 11(1): 69-73, 1986

Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer's disease: altered processing of prepro-vasoactive intestinal peptide and prepro-somatostatin. Neuropeptides 29(6): 325-330, 1995

Somatostatin and Alzheimer's disease. Molecular and Cellular Endocrinology 286(1-2): 104-111, 2008

Somatostatin and Alzheimer's disease. Archives of Gerontology & Geriatrics 21(1): 35-41, 1995

Somatostatin and Alzheimer's disease. Journal of Neurology 234(4): 266-267, 1987

Somatostatin in Alzheimer's disease and depression. Life Sciences 51(18): 1389-1410, 1992

Somatostatin and Alzheimer's disease: a hypothesis. Journal of Neurology 233(6): 370-372, 1986

Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia. Dementia and Geriatric Cognitive Disorders 8(4): 232-239, 1997